Deficiency of Smad7 enhances cardiac remodeling induced by angiotensin II infusion in a mouse model of hypertension
about
Electrophysiological Mechanisms of Bayés Syndrome: Insights from Clinical and Mouse StudiesSp1 Mediates a Therapeutic Role of MiR-7a/b in Angiotensin II-Induced Cardiac Fibrosis via Mechanism Involving the TGF-β and MAPKs Pathways in Cardiac Fibroblasts.miR-7a/b attenuates post-myocardial infarction remodeling and protects H9c2 cardiomyoblast against hypoxia-induced apoptosis involving Sp1 and PARP-1.TPGS/Phospholipids Mixed Micelles for Delivery of Icariside II to Multidrug-Resistant Breast Cancer.Regulation of TGF-β Family Signaling by Inhibitory Smads.Rapid atrial pacing induces myocardial fibrosis by down-regulating Smad7 via microRNA-21 in rabbit.Puerarin inhibits cardiac fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in myocardial infarction mice.Renal effects of cytokines in hypertension.Eplerenone Prevents Atrial Fibrosis via the TGF-β Signaling Pathway.The association of circulating miR-30a, miR-29 and miR-133 with white-coat hypertension.Sp1 Plays an Important Role in Vascular Calcification Both In Vivo and In Vitro.Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1.
P2860
Q26746021-030511FE-1E42-4B6C-A7F9-ABE5DFA1BFC9Q35553540-86FE8E39-F41D-49D1-B3EF-C7EAEF3F96F9Q37072777-939A95FF-F360-40C5-A71C-9E0356E17DBBQ38842165-5352E19A-F342-404D-97CD-A12A9A7D8BD8Q39029996-A1058135-C7C3-4E70-90A0-3EEF34246BAEQ41234674-81664369-3B55-45F7-ABF7-82B39D8D66D7Q41669202-4F89603E-FE7F-4F9F-8F12-9F91CF114CC7Q49997121-A5308B00-536C-4A5B-B051-8FF91FE6D04EQ50965106-8BE6EA4C-6A46-4A47-A3A9-D322CF5BECDAQ51024991-12AE28DF-1B6C-4D27-8DCD-139AE6A52D77Q51760049-7F100A40-8805-4E6B-B757-425F74A73462Q52881618-615EF7A5-EE49-44FB-8098-0211123D4BDA
P2860
Deficiency of Smad7 enhances cardiac remodeling induced by angiotensin II infusion in a mouse model of hypertension
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Deficiency of Smad7 enhances c ...... a mouse model of hypertension
@ast
Deficiency of Smad7 enhances c ...... a mouse model of hypertension
@en
Deficiency of Smad7 enhances c ...... a mouse model of hypertension
@nl
type
label
Deficiency of Smad7 enhances c ...... a mouse model of hypertension
@ast
Deficiency of Smad7 enhances c ...... a mouse model of hypertension
@en
Deficiency of Smad7 enhances c ...... a mouse model of hypertension
@nl
prefLabel
Deficiency of Smad7 enhances c ...... a mouse model of hypertension
@ast
Deficiency of Smad7 enhances c ...... a mouse model of hypertension
@en
Deficiency of Smad7 enhances c ...... a mouse model of hypertension
@nl
P2093
P2860
P50
P1433
P1476
Deficiency of Smad7 enhances c ...... a mouse model of hypertension
@en
P2093
Bryan P Yan
Cheuk-Man Yu
Li Hua Wei
Xiao Ru Huang
Yang Zhang
P2860
P304
P356
10.1371/JOURNAL.PONE.0070195
P407
P577
2013-07-23T00:00:00Z